Pennsylvania guide · Updated November 2026

Best Tirzepatide Providers in Pennsylvania

Anywhere in Pennsylvania, from Philadelphia to Pittsburgh and Erie, a clinician with a Pennsylvania license can prescribe tirzepatide in person or by telehealth, and a pharmacy registered with the State Board of Pharmacy can mail it to you. For weight loss alone, most plans won't pay: not Medical Assistance (Medicaid) since January 1, 2026, not the PEBTF plan for state employees, and job plans only where the employer bought a weight-loss benefit. On Medicare, the GLP-1 Bridge charges $50 a fill for some brand drugs if you qualify, and PACE is billed second. Paying cash, other online programs in our November price index charge $129 to about $432 a month for compounded tirzepatide, billed month to month; MaxLife's is $120 a month, flat: all-inclusive and the same price at every dose.

$120/mo flatMaxLife tirzepatide. All-inclusive, same price at every dose

Last updated

Tirzepatide medication vial with syringe

MaxLife Tirzepatide

Physician-guided weight loss, shipped to your door

$120/mo flatFlat price

All-inclusive, same price at every dose

(949) 704-1000

4.7on Trustpilot · 620+ reviews

  • All-inclusive
  • Same price at every dose
  • No membership fee
  • No hidden fees
  • Free online consultation
  • Free medical support

What could you lose?

230 lbs

≈ 17 lbsin about 3 months

≈ 39 lbsin about 1 year

Average results with brand tirzepatide (Zepbound®) plus diet and activity in the SURMOUNT-1 trial applied to your weight. Compounded tirzepatide was not studied in this trial. Individual results may vary.

Check Your Eligibility

Compounded medications are not FDA-approved. A licensed provider decides if treatment is right for you.

Who made this guide

Reviewed by the MaxLife operations team. How we made this page: we researched it from the sources listed below and drafted it with the help of AI tools. The MaxLife operations team reviews every page before it goes live, and a licensed clinician also reviews our medical articles. MaxLife, a telehealth company in Irvine, California, publishes this guide and sells one of its options; we have no Pennsylvania office and serve Pennsylvanians by mail. What changed in November 2026: the guide now keeps to what applies in Pennsylvania and links to our national guides for the rest.

Does your Pennsylvania insurance cover Zepbound or Wegovy for weight loss?

For weight loss alone, usually not. In November 2026, Medical Assistance (Medicaid), the plans for state workers and school retirees and the Pennie benchmark plan excluded these drugs, and Independence Blue Cross, Capital Blue Cross, UPMC Health Plan and Highmark covered them only where an employer added a weight-loss benefit. Medicare's $50 Bridge, PACE after it, and TRICARE pay, with conditions. Here is what each plan's own document says.

These rules are about FDA-approved drugs such as Zepbound® and Wegovy®. Compounded tirzepatide stays a cash purchase whatever your plan.

The fine print

Weight-loss drugs in Pennsylvania plans, in the plans' own words

What each plan's current document says about drugs such as Zepbound® and Wegovy® prescribed for weight loss, and when it applies. The highlighted words decide it.

  • 4exclude weight-loss drugs
  • 4only through a benefit an employer adds
  • 3pay, with conditions
  1. Pennsylvania Medicaid (Medical Assistance)All HealthChoices plans · January 1, 2026

    "Effective January 1, 2026, drugs containing a GLP-1 receptor agonist will not be covered for the treatment of overweight and obesity."

    DHS bulletin, November 24, 2025
    No, for adults
  2. PEBTF and REHPState employees and retirees · September 1, 2026

    Excluded: "Prescription drugs or medications prescribed primarily for weight loss, weight management, anti-obesity, or appetite suppression, regardless of whether they are FDA-approved or prescribed for other indications"

    PEBTF Summary Plan Description; REHP Benefits Handbook
    Excluded
  3. PSERS Health Options ProgramSchool retirees, Medicare drug plans · 2026

    Wegovy: "Excluded if used for weight loss only"

    HOP prior authorization criteria
    Not for weight loss alone
  4. Pennie plans (the state's benchmark)Benchmark plan for 2025 to 2027

    "Pharmacological therapy for weight reduction or diet agents unless Preapproved by the Health Benefit Plan"

    Pennsylvania benchmark plan (CMS)
    Excluded unless preapproved
  5. UPMC Health PlanAdvantage Choice list · January 1, 2027

    Not covered under the standard pharmacy benefit: "Medications used for weight loss." "Some excluded medications may be eligible for a coverage exception based on ... other custom plan benefits."

    UPMC Advantage Choice formulary, 2027
    Excluded; some plans add it
  6. Capital Blue CrossValue list · January 2027

    "Examples of contractual exclusions include: ... Anti-obesity agents (for example, Wegovy)." "Some members' employers may choose to purchase additional coverage for these drug classes"

    Capital Blue Cross Value formulary, January 2027
    Only if your employer buys it
  7. Independence Blue Cross (IBX)Fully insured plans · January 1, 2025

    IBX "will no longer offer coverage for drugs ... prescribed solely for weight loss." "Members who have a weight loss benefit through their employer still have coverage for GLP-1 medications, including Zepbound."

    IBX provider news; IBX, Zepbound for sleep apnea
    Only through your employer
  8. HighmarkEnhanced policy · October 15, 2026

    To start, "The member has a baseline BMI ≥ 40 kg/m2", plus related conditions and "healthy dietary changes for at least 6 months prior to initiation"

    Highmark policy J-1388-029
    Only with the benefit
  9. Medicare drug plansGLP-1 Bridge · to December 31, 2027

    Medicare GLP-1 Bridge: "Eligible beneficiaries will have a $50 copay."

    CMS, Medicare GLP-1 Bridge
    $50 a fill, if you qualify
  10. PACE and PACENETAge 65 and older · July 1, 2026

    Pharmacies submit claims to the Bridge (or Part D) "then to PACE as secondary payer."

    PACE bulletin PPB-26-004
    Billed second, after the Bridge
  11. TRICAREPrime and Select plans

    "TRICARE may cover prescription weight loss drugs for some beneficiaries when medically necessary" with a network prescription and prior authorization; not TRICARE For Life

    TRICARE
    Covered, with prior approval

Quotes from each plan's or agency's own document, checked November 2026. A plan's full certificate or drug list is the final word; for Geisinger Health Plan, ask Geisinger with your member ID.

Pennsylvania price table

Tirzepatide providers that serve Pennsylvania, compared

How we chose: a prescriber licensed in Pennsylvania, a pharmacy registered by the State Board of Pharmacy, one published price that counts memberships and visit fees, and follow-up care. MaxLife publishes this guide and sells one of these programs, so it comes first. Then come brand Zepbound® at LillyDirect and Pennsylvania practices and clinics, with each one's own prices and terms, checked November 2026.

ProgramPriceMembershipVisitNotes
MaxLifeFlat monthly price$120/mo flatall-inclusive, same price every monthNoneOnline intakereviewed by a licensed provider, usually within 24 hoursSame price at every dosehelp in Spanish
LillyDirect (brand Zepbound®)FDA-approved$299 to $449each fill; visits extraNoneYour own prescriberCounsel charges $29 a chat$449 at higher doses needs each refill within 45 daysneedles extra
OVYVO (Harrisburg, Blakely)Pennsylvania practice$75/mo or $750 a yearprescriber fees for brand Zepbound®; medicine at Lilly's pricesIncludedOnline (Fast-Track)or monthly visits on Integrated Care, $95 + $125/moPennsylvania residents only
TeleSlim (Pittsburgh, Philadelphia)Pennsylvania offices$99 consultationthen $99/mo or $899 a year; medicine extraSubscriptionPhysician telemedicineanywhere in PennsylvaniaPrescriptions go to your pharmacy
Medi-Weightloss (in person)$199 first monthcompounded tirzepatide offer; later months not publishedFrom $199/mo, plus a $199 first visitIn a clinicBerwyn, Coatesville, West Chester, Drexel HillFees vary by program and clinic
Elevation Medical Weight Loss (in person)$375 per 5-week vialcompounded tirzepatide at its first phase; rises by phase to $625 per 4-week vialNoneIn 15 officesaround Pittsburgh; provider visits freePrice rises by phase
IV Nutrition (in person)$280 for 1 month$560 for 3 monthsNoneWest Chester studioConsultation and labs not pricedcompounded or brand not stated

Out of 122 programs and options we read for Pennsylvanians, 80 serve the state; this table lists those with a Pennsylvania office or clinic that publish a price, and online programs that serve every state are in our national guide. Where others may suit you better: Pennsylvania practices see you in person or by their own telemedicine, LillyDirect sells the FDA-approved brand, and on Medicare, PACE or TRICARE a covered brand drug can cost less than any cash price. Companies change prices, so check the current one before you sign up; being listed here is not an endorsement.

Paying cash, other online programs charge $129 to about $432 a month for compounded tirzepatide, billed month to month, in our price index of November 2026, and some raise the price as the dose goes up. Among Pennsylvania clinics that publish a price, a first month at Medi-Weightloss comes to about $597 (a $199 new-patient visit, plans from $199 a month and a $199 first-month tirzepatide offer), and Elevation Medical Weight Loss charges $375 per 5-week vial at its first phase, visits included, more at later phases. Brand Zepbound® costs $299 to $449 a fill at LillyDirect, before visit fees and needles. What a year costs, prepaid plans included, is in our tirzepatide cost guide, and programs that serve every state are compared in our national guide.

MaxLife's price doesn't move with the dose: $120/mo flat, the same price at every dose. Members often ask at refill time whether they can move up to the next dose. Before each refill you answer a short check-in (your weight, current dose, appetite, any side effects and the date of your last injection), and the provider decides your dose and approves the refill; the price is the same either way.

Does Pennsylvania Medicaid cover Zepbound or Wegovy?

Not for weight loss in adults since January 1, 2026. The Department of Human Services' bulletin says that from that date "drugs containing a GLP-1 receptor agonist will not be covered for the treatment of overweight and obesity" (DHS bulletin, November 24, 2025), ending coverage that began in January 2023. The rule applies to fee-for-service and every HealthChoices plan, such as UPMC for You, Keystone First, AmeriHealth Caritas Pennsylvania, Highmark Wholecare, Jefferson Health Plans, Geisinger and UnitedHealthcare Community Plan (DHS plan map). Every earlier approval ended on December 31, 2025, "regardless of the condition being treated"; Saxenda® is no longer covered at all, while phentermine still is.

People under 21 are treated differently. In January 2026 DHS told its Medical Assistance Advisory Committee that people "under the age of 21 under the EPSDT (Early and Periodic Screening, Diagnostic, and Treatment) rules are required to get all medically necessary services regardless of whether or not they're a state plan benefit," and counted 1,112 appeals in the first full week of January, 68 for people under 21 (MAAC transcript). About 2.9 million Pennsylvanians had Medical Assistance in July 2026 (DHS monthly data report).

GLP-1 drugs stay covered, with prior authorization, for the uses below. The drug list for January 4, 2027 makes Wegovy® and the Zepbound® KwikPen® preferred drugs (Statewide PDL, 2027), but that only decides which drug is tried first for these uses; the weight-loss exclusion stays.

Medical Assistance

What Pennsylvania Medicaid still covers, with prior authorization

UseWho qualifies (main points)Which drug
Type 2 diabetesA diagnosis of diabetes, or a recent diabetes medicine other than metformin, SGLT-2 inhibitors or GLP-1sOzempic® and Trulicity® are preferred in 2026
Moderate to severe sleep apneaA recent BMI of 35 or more, confirmed sleep apnea with symptoms, and CPAP use or documented CPAP intolerance; a recent six-month lifestyle trialZepbound® only after Ozempic®, Wegovy® and Mounjaro® failed or weren't tolerated
Heart riskA recent BMI of 27 or more after a heart attack, a stroke or artery disease, prescribed by or with a specialist such as a cardiologistWegovy®, after Ozempic®
MASH (fatty liver disease with scarring)Moderate to advanced scarring (stage F2 or F3), prescribed by or with a liver specialistBy the same approval order

Every GLP-1 prescription needs prior authorization and is limited to a one-month supply per fill; approvals last up to 12 months for diabetes and up to 6 months for other uses. Source: DHS, prior authorization guidelines of March 2, 2026.

Does Highmark, IBX, Capital Blue Cross or UPMC cover Zepbound?

Only where your plan includes a weight-loss benefit, which for most job plans means your employer chose to buy it.

Aetna and UnitedHealthcare job plans work the same way: CVS Caremark, Aetna's pharmacy benefit manager, has listed Zepbound® as a preferred option since October 1, 2026 "for plan sponsors who elect to provide coverage" (CVS Health, May 28, 2026), and UnitedHealthcare calls its weight-loss coverage "an optional program" (UnitedHealthcare).

Highmark

Highmark covers Zepbound® and Wegovy® for weight loss only on plans with its anti-obesity benefit. Its Enhanced policy, in effect since October 15, 2026, asks an adult for a BMI of 40 or more plus prediabetes with abnormal blood fats or two listed conditions caused by obesity, and six months of documented diet and activity changes; Zepbound® is the preferred drug, and staying on it needs 7.5% weight loss (Highmark policy J-1388-029). Employers on the Standard policy use a BMI of 30, or 27 with a condition, after three months in a lifestyle program (Highmark policy J-1389-013).

Independence Blue Cross (IBX)

Since January 1, 2025, IBX's fully insured group and individual plans no longer cover drugs prescribed solely for weight loss (IBX provider news), and since May 1, 2025 its main formularies no longer cover Zepbound® for sleep apnea. Members with an employer weight-loss benefit keep GLP-1 coverage, Zepbound® included (IBX, Zepbound for sleep apnea), and GLP-1s stay covered for type 2 diabetes and heart disease with prior authorization.

Capital Blue Cross, UPMC Health Plan and Geisinger

Capital Blue Cross's 2027 Value list, used for its individual and Pennie plans, counts anti-obesity drugs among contractual exclusions that some employers buy back (Capital Blue Cross, January 2027), and UPMC Health Plan's 2027 Advantage Choice list excludes weight-loss drugs under the standard benefit, with exceptions for some custom plans (UPMC Health Plan, 2027). For Geisinger Health Plan, ask Geisinger about its drug list with your member ID.

Pennie plans

Pennsylvania's benchmark plan, the standard every Pennie plan builds on, excludes "pharmacological therapy for weight reduction" unless the plan preapproves it (CMS, Pennsylvania benchmark plan), and the 2027 drug lists from Ambetter, Capital Blue Cross, UPMC and Jefferson Health Plans exclude weight-loss drugs or don't list Zepbound® or Wegovy®. Open enrollment for 2027 runs from November 1, 2026 to January 15, 2027; enroll by December 15 for coverage from January 1 (Pennie), and individual premiums rise an approved average of 15.97% (Insurance Department, 2027 rates).

TRICARE and the VA

TRICARE Prime and Select plans may cover prescription weight-loss drugs when medically necessary, with prior authorization and a network prescription, but not TRICARE For Life (TRICARE). The VA asks for a BMI of 27 or more with a related condition and a lifestyle program such as MOVE! (VA criteria).

If your plan says no: Pennsylvania's external review

Pennsylvania runs its own free, binding external review for insured job plans, Pennie plans and plans you buy yourself: appeal to the insurer first, then ask the Insurance Department within four months of the final denial; a decision comes within 45 days, or 72 hours when your health is at serious risk (Insurance Department). A review can overturn a "not medically necessary" denial of a covered drug, but "a request for a non-covered service is not eligible," so a weight-loss exclusion stands. Self-funded job plans, Medicare and Medicaid have their own routes.

State employees, state retirees and school retirees: PEBTF, REHP and PSERS

No weight-loss drug coverage. The PEBTF plan for active state employees excludes weight-loss drugs "regardless of whether they are FDA-approved or prescribed for other indications" (PEBTF Summary Plan Description), and the REHP plan for retired state employees uses the same words (REHP Benefits Handbook). Open enrollment for 2027 left the drug plan as it was (PEBTF open enrollment newsletter). The medical plan covers a weight management program PEBTF approves and bariatric surgery that meets its rules. The Senate's own staff plan stopped covering weight-loss GLP-1s on July 1, 2025 (Spotlight PA, June 12, 2025).

School retirees in PSERS's Health Options Program: its Medicare drug plans exclude Wegovy® "if used for weight loss only" and cover it, with prior authorization, for heart risk or MASH (HOP criteria); Zepbound® is not on the 2027 Medicare Plus formulary (HOP 2027 formulary). Active teachers and school staff are on their district's plan, which sets its own rules.

Retirees with Medicare in REHP's drug plan or HOP's drug plan are in employer group Part D plans, a plan type the Medicare GLP-1 Bridge accepts, so those who meet its criteria may get the Zepbound® KwikPen® or Wegovy® for $50 a fill (next section).

Medicare's $50 Bridge, PACE and PACENET for Pennsylvanians 65 and older

More than one in five Pennsylvanians is 65 or older, and 3,041,571 had Medicare in July 2026 (CMS, Medicare enrollment). Medicare drug plans can't pay for weight loss, but from July 1, 2026 to December 31, 2027 the Medicare GLP-1 Bridge charges $50 a fill for the Zepbound® KwikPen®, Wegovy® or Foundayo™ if you meet its BMI and health criteria (Medicare.gov). People with type 2 diabetes, sleep apnea or fatty liver disease use their Part D plan instead, and compounded tirzepatide isn't included.

PACE and PACENET, Pennsylvania's drug programs for people 65 and older with incomes up to $33,500 single or $41,500 married (PACE), work with the Bridge: since July 1, 2026, pharmacies submit claims to the Bridge first, "then to PACE as secondary payer" (PACE bulletin PPB-26-004). The bulletin doesn't say what a cardholder pays in the end, so call PACE at 1-800-225-7223 before you fill. Free Medicare counseling: PA MEDI, 1-800-783-7067 (Department of Aging, PA MEDI).

From Erie to Philadelphia, by mail

MaxLife compounded tirzepatide: $120 a month, flat. All-inclusive, the same price at every dose. Spanish-speaking staff can help.

Check if you qualify

After Rite Aid: where Pennsylvanians fill tirzepatide, and who may mail it

When Rite Aid filed its second bankruptcy in May 2025, it had 349 licensed pharmacies in Pennsylvania, 11.7% of the state's 2,964 (Center for Rural Pennsylvania). Its Pennsylvania stores have since closed, and CVS took the prescription files of 173 of them (WVIA, September 2025). The Insurance Department asked insurers to move existing prior authorizations to the new pharmacy automatically (Insurance Department, August 2025).

Brand Zepbound® can still be filled at a local pharmacy or picked up through LillyDirect. Compounded tirzepatide usually comes by mail, often from another state. A pharmacy outside Pennsylvania needs a nonresident pharmacy registration from the State Board of Pharmacy in Harrisburg before it ships any prescription here, one per location; registration numbers start with "NP", and all registrations expire on August 31 of odd-numbered years, so current ones run to August 31, 2027 (Pharmacy Act, section 4.1; State Board of Pharmacy). Every package must carry a toll-free number that reaches a pharmacist at least six days and 40 hours a week. Compounding must follow federal section 503A and the current USP standards (49 Pa. Code § 27.601); Pennsylvania has no separate sterile-compounding license and no license category for out-of-state 503B outsourcing facilities (Board of Pharmacy minutes, May 2, 2023).

Out-of-state pharmacies held 1,333 of Pennsylvania's 4,319 pharmacy licenses (30.9%) in the Board's latest report, up from 1,165 three years earlier, while in-state permits fell from 3,277 to 2,986. PALS, the state's free license lookup, shows each pharmacy's registration, its status, its address and any discipline; the check is in three steps further down. The table below lists the pharmacies that held an active nonresident registration in November 2026 and whose business a public source ties to compounded tirzepatide.

Licensed for Pennsylvania

Out-of-state pharmacies hold almost a third of Pennsylvania's pharmacy licenses

In-state pharmacy permits and nonresident pharmacy registrations by fiscal year, from the State Board of Pharmacy's own report.

  • Pharmacy permits in Pennsylvania
  • Nonresident registrations (out of state)
  1. FY 2021-2226.2% out of state (3,277 in Pennsylvania, 1,165 out of state)
  2. FY 2022-2328.0% out of state (3,230 in Pennsylvania, 1,255 out of state)
  3. FY 2023-2430.6% out of state (2,996 in Pennsylvania, 1,321 out of state)
  4. FY 2024-2530.9% out of state (2,986 in Pennsylvania, 1,333 out of state)

Source: State Board of Pharmacy, FY 2024-25 Annual Financial Report (counts from about November 2024, before the 2025 Rite Aid closures). Shares are our math.

Registered for Pennsylvania

Pharmacies registered to ship compounded tirzepatide to Pennsylvanians

Each held an active Pennsylvania nonresident pharmacy registration in November 2026, and a public source links the business to compounded tirzepatide (for multi-site businesses, at company level). This is not a list of MaxLife's pharmacies, and a registration is not an endorsement.

PharmacyWhere it isType
Hallandale PharmacyFort Lauderdale, Broward County, FL503A
Southend PharmacyHouston, Harris County, TX503A
Empower PharmacyHouston, Harris County, TX503A
Drug CraftersFrisco, Collin County, TX503A
Premium Compounding PharmacyDecatur, Morgan County, AL503A
White Label Pharmacy (Nova Pharmacy)Katy, Harris County, TXPharmacy; FDA also lists it as a 503B
HealthWealthHouston, Harris County, TX503A
Strive PharmacyGilbert, Maricopa County, AZ503A
Strive Pharmacy MissouriFenton, St. Louis County, MO503A
Strive Pharmacy TampaTampa, Hillsborough County, FL503A
Strive Pharmacy TexasSan Antonio, Bexar County, TX503A
Strive Pharmacy VirginiaLeesburg, Loudoun County, VA503A
EdenAlbuquerque, Bernalillo County, NM503A
OptioRx - 290Columbus, Franklin County, OH503A
RXCompoundStore.comMiami, Miami-Dade County, FL503A
Manifest PharmacyGreer, Greenville County, SC503A

Source: PALS, Pennsylvania Department of State, November 2026. For Manifest Pharmacy and RXCompoundStore.com, the only public link is one telehealth program's January 2026 announcement naming them among the pharmacies that prepare its compounded semaglutide and tirzepatide. Registrations run to August 31, 2027 and a status can change, so check PALS before you order.

Winter is the shipping risk: keeping tirzepatide from freezing in Pennsylvania

Tirzepatide has to stay cold but must never freeze, and in a Pennsylvania winter a box left on a porch can freeze anywhere in the state. From December 2025 to February 2026, the overnight low fell to 32°F or below on 76 of 90 nights in Philadelphia and on 86 in Allentown and Harrisburg; Pittsburgh reached -11°F on January 31 (NOAA station data, our count). The Governor declared a disaster emergency for the whole state ahead of the January 24 to 26 winter storm (Governor's office, January 23, 2026). Summer matters mostly in the southeast: Philadelphia passed Zepbound®'s 86°F room-temperature limit on 56 of 122 days in summer 2026 and hit 103°F on July 2.

Freezing nights

Nights at or below 32°F, December 2025 to February 2026

Each airport station's overnight lows over the 90 nights of last winter, with the coldest reading.

  1. Allentowncoldest -9°F, January 2186 of 90
  2. Harrisburgcoldest 0°F, January 3186 of 90
  3. Williamsportcoldest -3°F, January 2885 of 90
  4. Eriecoldest -9°F, January 3083 of 90
  5. Wilkes-Barre/Scrantoncoldest -3°F, February 881 of 90
  6. Pittsburghcoldest -11°F, January 3177 of 90
  7. Philadelphiacoldest 8°F, February 876 of 90

Source: NOAA Regional Climate Centers, ACIS daily station data (ACIS), our count. All seven stations reported all 90 days.

Delivery

Four winter delivery facts, and what to do

  • Label
    Zepbound® must never freeze

    Lilly's label: "Do not freeze ZEPBOUND. Do not use ZEPBOUND if frozen" (Lilly). Compounded tirzepatide follows its own pharmacy label, so ask the pharmacy.

  • Rule
    Cold packs by Pennsylvania rule

    A pharmacy may mail a drug that heat or cold can damage only "in a manner which would preserve the integrity of the drug, such as cold packs or other temperature control devices and sensors that would alert the patient if the integrity of the drug was compromised" (49 Pa. Code § 27.18).

  • Porch
    Be home for it

    Last winter the daytime high stayed at or below freezing on 43 days in Erie and 39 in Pittsburgh (NOAA, our count). Ask for expedited shipping, bring the box in at once and put the medicine in the fridge. If it arrives frozen, call the pharmacy before you use it.

  • Refills
    No early-refill law for insurers

    We found no Pennsylvania law that makes insurers pay for early refills in a disaster; the Insurance Department only "encourages" them (Insurance Department, 2024). If your prescriber can't be reached, a pharmacist may give one emergency supply of a non-controlled maintenance drug (Act 8 of 2018).

What Pennsylvania requires of an online prescriber

A clinician who treats you while you're in Pennsylvania must hold a Pennsylvania license, "whether the provision of services occurs in person or via an electronic interaction such as a telehealth consultation" (Department of State, telemedicine FAQ). The medical, osteopathic and nursing boards have no telemedicine rule: the Department of State says the practice acts and rules "do not currently address" telemedicine and that "there is nothing that would prohibit licensees from using telehealth/telemedicine so long as doing so complies with the standards of acceptable and prevailing medical practice."

Act 42 of 2024 counts real-time audio or video visits and asynchronous exchanges, such as a patient's "self-reported medical history," as telemedicine, and holds them to "the same standard of care that would apply ... in an in-person setting" (Act 42 of 2024). The one Pennsylvania rule that requires an in-person physical exam before a first prescription covers controlled substances such as phentermine; tirzepatide is not a controlled substance (49 Pa. Code § 16.92).

Doctors licensed elsewhere can get a Pennsylvania license through the Interstate Medical Licensure Compact, which Pennsylvania fully put in place on July 7, 2025 (Governor's office). Nurse practitioners prescribe under a collaborative agreement with a Pennsylvania-licensed physician (49 Pa. Code § 21.285), and physician assistants under a written agreement with a supervising physician.

3-step check

Before you pay: check the prescriber and the pharmacy on PALS

  1. Look up the prescriber

    Search the doctor, nurse practitioner or physician assistant by name in PALS, the Department of State's free license lookup. The Pennsylvania license should be active, and PALS shows any disciplinary action.

  2. Ask who fills it

    Before you pay, ask the program in writing which pharmacy fills the prescription and where it ships from.

  3. Check the pharmacy

    In PALS, choose Facility and the State Board of Pharmacy. A pharmacy outside Pennsylvania should show an active nonresident pharmacy registration (an NP number) at the address on your label, current to August 31, 2027.

Tirzepatide across Pennsylvania: Philadelphia, the Lehigh Valley, Harrisburg, Scranton, State College, Pittsburgh and Erie

Online care reaches every county by mail, but each region has its own health systems, clinics and winters.

Regions

Pennsylvania's regions at a glance

RegionPlaces (county)What to know
Philadelphia and the southeast suburbsPhiladelphia; Norristown and King of Prussia (Montgomery); Doylestown (Bucks); Media (Delaware); West Chester (Chester)A third of Pennsylvanians (32.5%). Jefferson, Temple and Main Line Health run weight-management programs, and 22 CVS MinuteClinics nearby have weight-loss program pages. Philadelphia hit 103°F on July 2, 2026.
Lehigh ValleyAllentown (Lehigh), Bethlehem and Easton (Northampton), Jim Thorpe (Carbon)Lehigh Valley Health Network and St. Luke's run weight-management programs; Lilly's new plant is planned in Lehigh County. 42.6% of Allentown residents speak Spanish at home (ACS 2020 to 2024).
NortheastScranton (Lackawanna), Wilkes-Barre and Hazleton (Luzerne), Stroudsburg (Monroe)The highest regional adult obesity estimate (36.7%). OVYVO has an office in Blakely; more than half of Hazleton residents speak Spanish at home (ACS 2020 to 2024).
South CentralHarrisburg (Dauphin), Carlisle (Cumberland), Lancaster, York, Reading (Berks)The state boards, DHS, the Insurance Department and PEBTF are in Harrisburg. WellSpan, UPMC and Tower Health run weight-management programs; more than half of Reading residents speak Spanish at home (ACS 2020 to 2024).
CentralState College (Centre), Altoona (Blair), Johnstown (Cambria)23.5% of residents are 65 or older (Census, 2025). The lowest broadband share of any region: 84.6% of households (ACS 2020 to 2024). Johnstown's high stayed at or below freezing on 47 days last winter.
North Central and the Northern TierWilliamsport (Lycoming), Danville (Montour), Bloomsburg (Columbia), Wellsboro (Tioga)The most rural region (56.3% in 2020) and Geisinger's home in Danville. In Cameron County the only pharmacy was a Rite Aid (Center for Rural Pennsylvania).
NorthwestErie, Meadville (Crawford), Hermitage (Mercer), WarrenUPMC runs a weight-management program in Erie, where the airport fell to -9°F on January 30, 2026. Forest County has the state's highest adult obesity estimate (40.4%) and no hospital.
SouthwestPittsburgh (Allegheny), Greensburg (Westmoreland), Washington, Cranberry Township (Butler)UPMC and Allegheny Health Network run weight-management programs, and Elevation Medical Weight Loss has 15 offices. Pittsburgh fell to -11°F on January 31, 2026.

Sources: U.S. Census Bureau (population, age, language), CDC PLACES (obesity), NOAA (temperatures), the Center for Rural Pennsylvania and each health system's and clinic's own pages, checked November 2026.

By the numbers

Weight, age and language in Pennsylvania

  • 33.5%of Pennsylvania adults have obesity (2025)
  • 29.5% to 40.4%by county, from Chester to Forest
  • 21.5%of Pennsylvanians are 65 or older (2025)
  • 5.9%speak Spanish at home (2025)

Sources: CDC BRFSS 2025 (adults); CDC PLACES, age-adjusted county estimates (2024 release, 2022 data); U.S. Census Bureau, ACS 2025 (age 5 and older for language).

What else changed for Pennsylvanians

  • Lilly is building in the Lehigh Valley. On January 30, 2026 the Governor announced a $3.5 billion Eli Lilly plant in Lehigh County with 850 jobs and $100 million in state support; Lilly said it adds "capacity for next-generation weight-loss medicines" (Governor's office, January 30, 2026).
  • Ask the pharmacy for the cash price. Under Act 34 of 2025 you are entitled, on request, to know a pharmacy's current retail price for a brand-name drug and any generic equivalent (Board of Pharmacy notice).

What MaxLife offers Pennsylvanians

MaxLife serves Pennsylvania by mail from Irvine, California; we have no Pennsylvania office. Compounded tirzepatide is $120 a month, flat: all-inclusive and the same price at every dose, with no membership fee. The provider review, medicine if prescribed, supplies and free expedited shipping in an insulated box are included, and a licensed partner pharmacy authorized to serve Pennsylvania fills the prescription. The whole program is on our tirzepatide program page.

A licensed provider reviews your online intake, health history and clinical records, usually within 24 hours, can follow up with questions, and you can ask for a video visit. Completing the intake doesn't guarantee a prescription.

About 5.9% of Pennsylvanians speak Spanish at home (U.S. Census Bureau), and MaxLife has Spanish-speaking staff who can guide you through the program and support you during treatment.

Another option may suit you better. If Medicare's Bridge, TRICARE or an employer weight-loss benefit covers Zepbound® or Wegovy® for you, your copay may be lower than paying cash. MaxLife offers compounded tirzepatide only, so for the FDA-approved brand you would go to LillyDirect or your own prescriber, and the Pennsylvania practices in the price table can see you in person. MaxLife is a patient management platform, not a pharmacy or a drug maker, and independent licensed providers decide whether a prescription is right for you.

MaxLife's fine print, in plain words

  • $120/mo flat, the same price at every dose.
  • Cancel anytime with notice before your next billing period.
  • Medicine costs are not refundable.
  • You may be able to use HSA or FSA funds. Check with your plan.
  • Already a MaxLife member? We offer a price match for existing customers.

Frequently asked questions

More questions from Pennsylvanians

It depends on your coverage. On Medicare, the GLP-1 Bridge charges $50 a fill for some brand drugs if you qualify, with PACE billed second, and some job plans cover Zepbound® or Wegovy® when the employer bought the weight-loss benefit. Paying cash, MaxLife's compounded tirzepatide is $120 a month, flat, the same at every dose; LillyDirect sells brand Zepbound® from $299 a fill, and Pennsylvania practices such as OVYVO, TeleSlim and Elevation Medical Weight Loss offer care in the state.
Yes, if your doctor is licensed in Pennsylvania and decides it's right for you. Since the shortage ended, the prescriber has to document a change that makes a significant difference for you. Expect to pay cash: plan coverage is written for FDA-approved drugs, and compounded tirzepatide isn't FDA-approved.
Online programs serve the whole state by mail; MaxLife is one, with no Pennsylvania office and free expedited shipping if a provider prescribes. In person, Medi-Weightloss has clinics in Chester and Delaware counties, Elevation Medical Weight Loss has 15 offices around Pittsburgh, OVYVO prescribes brand Zepbound® from Harrisburg and Blakely, and health systems such as Jefferson, UPMC and Allegheny Health Network run weight-management programs.
When a licensed provider prescribes, a licensed partner pharmacy authorized to serve Pennsylvania fills the prescription and mails it to you. Among our partner pharmacies, Hallandale Pharmacy, Southend Pharmacy and Health Wealth Pharmacy held an active Pennsylvania nonresident pharmacy registration in November 2026 (PALS, Pennsylvania Department of State). The label names the pharmacy that filled your prescription, and you can look up its registration in PALS.
Sí, necesita una receta de un proveedor con licencia de Pennsylvania, que puede atenderle en persona o por telemedicina. En MaxLife hay personal que habla español, y enviamos el tratamiento por correo a todo el estado. La tirzepatida compuesta cuesta $120 al mes, precio fijo, todo incluido y el mismo en cualquier dosis. Desde el 1 de enero de 2026, Medicaid de Pensilvania (Medical Assistance) ya no cubre estos medicamentos para bajar de peso en adultos; si tiene Medicare, pregunte por el programa GLP-1 Bridge, que cobra $50 por surtido si cumple los requisitos. La tirzepatida compuesta no tiene aprobación de la FDA.

Anywhere in Pennsylvania, start online

See in about 2 minutes if MaxLife compounded tirzepatide suits you: $120 a month, flat. All-inclusive, the same price at every dose.

Check if you qualify
Sources

Prices and plan rules were taken from public pages in November 2026 and may change, so confirm them before you enroll. Zepbound®, Mounjaro® and KwikPen® are registered trademarks and Foundayo™ is a trademark of Eli Lilly and Company; Wegovy®, Ozempic® and Saxenda® are registered trademarks of Novo Nordisk. MaxLife is not affiliated with the other companies or plans named.

Our editorial disclosure

How we handle the conflict of interest

MaxLife publishes this guide and sells one of the options in it. We decided what to list before we gathered prices: programs and Pennsylvania practices that publish a price and use a prescriber licensed in Pennsylvania. Plan rules come from each plan's or the state's own documents, and where a plan may pay for a brand drug, we say so.

  • Prices and policies come from each program's own website, checked November 2026.
  • Pennsylvania rules come from state law, the Department of State, DHS bulletins and plan documents.
  • Memberships, visits and money paid up front are counted in the price table.
  • We list MaxLife first, and we say where another option may suit you better.
Last updated: November 19, 2026

Did something change?

Pennsylvania insurers publish their 2027 drug lists and rules over the winter. Tell us what changed and we'll check it and fix the page.

web@maxlife.com

Medical and regulatory note: This page is for information only and is not medical or legal advice. Compounded medications are not FDA-approved. Prescription treatment is available only if a licensed provider decides it is right for you.